The expanding oncology pipeline in the USA is a key driver for cytotoxic drug demand, with over 1,000 oncology drugs in development. Advancements in ...
Heartseed Inc. and Novo Nordisk - in partnership since June 2021 - have announced that the first patient has been successfully dosed in a clinical study with HS-001, a cell therapy designed to ...
SY-001 is under development for the treatment of advanced solid tumors including advanced ovarian cancer and pancreatic cancer. It comprises of induced pluripotent stem cells derived macrophages which ...
Kina Bank is committed to giving back to the communities we operate in. Our commitment to giving back stems from our core values of Serve and Together, as we believe that by working and serving ...